Breathe Well Live Well
|
22 million American asthma sufferers at risk this winter
WDAM-TV Gayle Richardson is breathing easier these days since she has her asthma under control. But certain things trigger her condition, especially this time of year. "I have more issues with asthma in the wintertime because of the colds and the flu virus … |
View full post on asthma – Google News
|
UW wins $70 million grant for asthma research
Milwaukee Journal Sentinel "Our ongoing efforts to more effectively treat those affected by the urban asthma epidemic are critical to the well-being and future quality of life for millions of children who suffer with this disease, and promise to help others around the globe as … Kids to be injected with cockroach antigen in asthma study |
View full post on asthma – Google News
Milwaukee Business Journal |
UW awarded $70 million to continue asthma research in inner city
UW Badger Herald A longstanding University of Wisconsin project researching asthma in people living in the inner city got a $70 million grant, marking the largest award ever for the UW School of Medicine and Public Health. The grant will be used to continue research … UW Med School to use $70 million grant to study asthma UW-Madison awarded $70M NIH grant for asthma research Record grant will continue inner-city asthma research |
View full post on asthma – Google News
Milwaukee Business Journal |
UW Med School to use $70 million grant to study asthma
Madison.com The $70 million federal grant, the largest ever received by the medical school, will continue the work of the Inner-City Asthma Consortium. The consortium, which started in 2002 and is based at the medical school, aims to better understand, prevent and … UW-Madison awarded $70M NIH grant for asthma research Largest grant ever awarded to UW School of Medicine and Public Health will … |
View full post on asthma – Google News
|
Fight fat with an asthma drug: Neothetics sets terms for $60 million IPO
Nasdaq Neothetics, a biotech targeting fat reduction with an injectable formulation of an approved asthma drug, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $60 million by offering 4.3 million shares at a price range … |
View full post on asthma – Google News
Belfast Telegraph |
More than a million people suffering from asthma are missing out on key yearly …
Belfast Telegraph "With the worrying scale of prescribing errors identified by the National Review of Asthma Deaths, it's vital that doctors and nurses do everything they can to follow up with patients to review their medicines, especially as asthma can vary hugely over … Over A Million People Suffering From Asthma Aren't Receiving Yearly Checks … Asthma patients' lives 'at risk' by missing annual checks Welsh asthma sufferers missing crucial checks |
View full post on asthma – Google News
|
Annual Medicaid costs for pediatric asthma-related ED visits topped $270 million
Healio State Medicaid programs spent an estimated $272 million on pediatric asthma-related ED visits in 2010, according to recent CDC data. The researchers estimated state-based costs for asthma-related ED visits among children aged younger than 18 years, … |
View full post on asthma – Google News
University of Rochester Newsroom |
$3.6 Million Grant Funds Asthma Study for Urban Teens
University of Rochester Newsroom As schoolchildren enter their teenage years, they tend to start making more of their own health care decisions. But that transition can be challenging, and certain behaviors — such as making sure they take their daily asthma medication — can … |
View full post on asthma – Google News
Reuters UK |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Fox Business AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest drugmaker – subject of a … AstraZeneca extends global shopping spree with $232M asthma drug deal Synairgen breathes easier with $225M from Astrazeneca for its asthma drug |
View full post on asthma – Google News
Reuters |
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Reuters AstraZeneca plans to start a mid-stage Phase IIa study with the drug in early 2015 in patients with severe asthma, building on results from an initial Phase lla trial in a broad asthma population. Severe asthma is a growing focus for major drugmakers … Synairgen shares soar on AstraZeneca asthma deal AstraZeneca licenses rights to Synairgen asthma drug |
View full post on asthma – Google News